Kymanox
58 Case Studies
A Kymanox Case Study
Kymanox partnered with virtual pharmaceutical stakeholders to overcome development and manufacturing challenges for a pediatric neurological orphan drug. The customer, a virtual pharmaceutical company, faced significant hurdles in formulating a stable powder for oral solution that would ensure pediatric patient compliance and dosing accuracy. They also needed a custom packaging solution for large dose sizes and a thermolabile API, all while meeting an accelerated development timeline to serve a critically underserved patient population.
Kymanox implemented a comprehensive solution that included developing innovative custom packaging and employing Quality by Design principles. By managing the complete project lifecycle from CDMO selection to regulatory submission, Kymanox achieved a 6-month reduction in the development timeline and a 25% cost reduction. The vendor successfully delivered a high-quality, stable drug product within twelve months, exceeding client expectations and ensuring timely market access for the pediatric patients in need.
Virtual Pharmaceutical Stakeholders